Wikidata

(Q63337355)

English

Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration

clinical trial

In more languages

Statements

title
A Phase 2, Multi-centre, Randomised, Double-masked, Placebo-controlled, Parallel-group Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of GSK933776 in Adult Patients With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) (English)
0 references
medical condition
atrophy
0 references
macular degeneration
0 references
sponsor
GSK
0 references
country
Canada
0 references
start time
1 June 2011
0 references
end time
1 April 2016
0 references
number of participants
191
0 references
research site
GSK
0 references
minimum age
55 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63337355&oldid=1857161638"